Lv2
140 积分 2023-12-14 加入
The RAS-MEK-ERK pathway in low-grade serous ovarian cancer
4天前
已完结
The RAS-MEK-ERK pathway in low-grade serous ovarian cancer
8天前
已完结
Final overall survival analysis among patients with folate receptor alpha-positive, platinum-resistant ovarian cancer treated with mirvetuximab soravtansine versus investigator's choice chemotherapy in phase II MIRASOL (GOG-3045/ENGOT-ov55) study
8天前
已完结
A wolf in sheep's clothing: A microscopic gastrointestinal stromal tumor arising in gastric leiomyoma
1个月前
已完结
An update on the role of SMARCA4 deficiency in gynecological neoplasms: how and where
2个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
5个月前
已完结
Result of the treatment of 55 cases of slow infectious endocarditis with penicillin
5个月前
已关闭
[Guideline for HER2 testing in breast cancer (2024 version)]
6个月前
已完结
[Expert consensus on the prenatal diagnosis and genetic counseling for uniparental disomy-related imprinting disorders]
7个月前
已完结
[Chinese expert consensus on clinical practice of MET detection in non-small cell lung cancer]
8个月前
已完结
皖公网安备34019202002308